Zaguirre, Baby Girl .

HRN: 27-96-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2025
CEFOTAXIME 500MG (VIAL)
10/15/2025
10/22/2025
IV
60mg
Q8
Multiple CHD
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Cardiovascular    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: